{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:10:46Z","timestamp":1794276646374,"version":"4.9.0"},"reference-count":63,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202163041","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:16:52Z","timestamp":1621887412000},"source":"Crossref","is-referenced-by-count":9,"title":["Economic evaluations addressing diagnosis and treatment strategies for neglected tropical diseases: an overview"],"prefix":"10.1590","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-2981","authenticated-orcid":false,"given":"T\u00e1lia Machado de","family":"Assis","sequence":"first","affiliation":[{"name":"Instituto Ren\u00e9 Rachou,  Brazil; Centro Federal de Educa\u00e7\u00e3o Tecnol\u00f3gica de Minas Gerais,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rabello","sequence":"additional","affiliation":[{"name":"Instituto Ren\u00e9 Rachou,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gl\u00e1ucia","family":"Cota","sequence":"additional","affiliation":[{"name":"Instituto Ren\u00e9 Rachou,  Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2021]]},"reference":[{"key":"ref1","series-title":"Control of neglected tropical diseases"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"5245021","DOI":"10.1155\/2017\/5245021","article-title":"Emerging and neglected infectious diseases: insights, advances, and challenges","volume":"2017","author":"Nii-Trebi NI","year":"2017","journal-title":"Biomed Res Int"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.2174\/1568026618666181106124015","article-title":"Alleviating the neglected tropical diseases: recent developments in diagnostics and detection","volume":"18","author":"Hazra S","year":"2018","journal-title":"Curr Top Med Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40249-018-0444-1","article-title":"Innovation in neglected tropical disease drug discovery and development","volume":"7","author":"Weng HB","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"ref5","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond MF","year":"2006","edition":"3rd"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/lary.23943","article-title":"Health economic evaluation: important principles and methodology","volume":"123","author":"Rudmik L","year":"2013","journal-title":"Laryngoscope"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1302\/0301-620X.98B2.37643","article-title":"Guidelines for reporting health economic research","volume":"98-B","author":"Haddad FS","year":"2016","journal-title":"Bone Joint J"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003527","article-title":"Health economic evaluations of Visceral leishmaniasis treatments: a systematic review","volume":"9","author":"Marinho DS","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jval.2013.02.010","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","volume":"16","author":"Husereau D","year":"2013","journal-title":"Value Health"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2334-7-3","article-title":"Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting","volume":"7","author":"Reithinger R","year":"2007","journal-title":"BMC Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40249-018-0389-4","article-title":"Health economic evaluation of moist wound care in chronic cutaneous leishmaniasis ulcers in Afghanistan","volume":"7","author":"Stahl HC","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1111\/j.1365-3156.2007.01962.x","article-title":"The cost-effectiveness of cutaneous leishmaniasis patient management during an epidemic in Chaparral, Colombia in 2004","volume":"12","author":"Vega JC","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jebm.12245","article-title":"Cost-effectiveness analysis of thermotherapy versus pentavalent antimonials for the treatment of cutaneous leishmaniasis","volume":"10","author":"Cardona-Arias JA","year":"2017","journal-title":"J Evid Based Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12889-018-5060-2","article-title":"Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia","volume":"18","author":"Cardona-Arias JA","year":"2018","journal-title":"BMC Public Health"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005459","article-title":"Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis","volume":"11","author":"Berger BA","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/tmi.12996","article-title":"Cost-effectiveness of liposomal amphotericin B in hospitalised patients with mucocutaneous leishmaniasis","volume":"22","author":"Mistro S","year":"2017","journal-title":"Trop Med Int Health"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007856","article-title":"Intralesional infiltration versus parenteral useof meglumine antimoniate for treatment ofcutaneous leishmaniasis: a cost-effectiveness analysis","volume":"13","author":"Brito NC","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1590\/0102-311x00136419","article-title":"Economic impact of localized cutaneous leishmaniasis on adult patients of a referral service in Belo Horizonte, Minas Gerais State, Brazil","volume":"36","author":"Galv\u00e3o EL","year":"2020","journal-title":"Cad Saude Publica"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0454-2020","article-title":"Estimating direct costs of the treatment for mucosal leishmaniasis in Brazil","volume":"54","author":"Carvalho JP","year":"2021","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4269\/ajtmh.2008.79.53","article-title":"Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks","volume":"79","author":"Wilson LS","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1111\/j.1537-2995.2010.02686.x","article-title":"Cost-effectiveness of screening the US blood supply for Trypanosoma cruzi","volume":"50","author":"Agapova M","year":"2010","journal-title":"Transfusion"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002776","article-title":"Opportunity cost for early treatment of Chagas disease in Mexico","volume":"8","author":"Ramsey JM","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006809","article-title":"The economic value of identifying and treating Chagas disease patients earlier and the impact on Trypanosoma cruzi transmission","volume":"12","author":"Bartsch SM","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004528","article-title":"Cost-effectiveness of blood donation screening for Trypanosoma cruzi in Mexico","volume":"10","author":"S\u00e1nchez-Gonz\u00e1lez G","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bjhh.2016.11.007","article-title":"Seroprevalence, cost per donation and reduction in blood supply due to positive and indeterminate results for infectious markers in a blood bank in Lima, Peru","volume":"39","author":"Moya-Salazar J","year":"2017","journal-title":"Rev Bras Hematol Hemoter"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.actatropica.2011.02.012","article-title":"Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area","volume":"118","author":"Sicuri E","year":"2011","journal-title":"Acta Trop"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.actatropica.2015.04.014","article-title":"Economic evaluation of Chagas disease screening in Spain","volume":"148","author":"Imaz-Iglesia I","year":"2015","journal-title":"Acta Trop"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/S2214-109X(17)30073-6","article-title":"Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis","volume":"5","author":"Requena-M\u00e9ndez A","year":"2017","journal-title":"Lancet Glob Health"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1076-6332(96)80503-4","article-title":"Cost-effectiveness of magnetic resonance imaging in specific situations in India","volume":"3","author":"Shah VC","year":"1996","journal-title":"Acad Radiol"},{"key":"ref30","first-page":"203","article-title":"An\u00e1lisis farmacoecon\u00f3mico del esquema corto de praziquantel en el tratamiento de la neurocisticercosis","volume":"138","author":"Medina-Santill\u00e1n R","year":"2002","journal-title":"Gac Med Mex"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0035-9203(02)90241-5","article-title":"Evaluation of the ICT whole-blood antigen card test to detect infection due to Wuchereria Bancrofti in Sri Lanka","volume":"96","author":"Chandrasena TG","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1365-3156.1996.d01-82.x","article-title":"Cost and cost effectiveness of mass diethylcarbamazine chemotherapy for the control of Bancroftian filariasis: comparison of four strategies in Tanzania","volume":"1","author":"Michael E","year":"1996","journal-title":"Trop Med Int Health"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1179\/000349802125002428","article-title":"Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphaticf filariasis","volume":"96","author":"Krishnamoorthy K","year":"2002","journal-title":"Ann Trop Med Parasitol"},{"key":"ref34","article-title":"The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007)","volume":"4","author":"Chu BK","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref35","first-page":"728","article-title":"Investment success in public health: an analysis of the cost-effectiveness and cost-benefit of the Global Programme to Eliminate Lymphatic Filariasis","volume":"64","author":"Turner HC","year":"2017","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4269\/ajtmh.14-0644","article-title":"Cost analysis of tests for the detection of Schistosoma mansoni infection in children in western Kenya","volume":"92","author":"Worrell CM","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1046\/j.1365-3156.2000.00530.x","article-title":"A comparative analysis of the cost-effectiveness of treatment based on parasitological and symptomatic screening for Schistosoma mansoni in Burundi","volume":"5","author":"Carabin H","year":"2000","journal-title":"Trop Med Int Health"},{"key":"ref38","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760180347","article-title":"The cost of a disease targeted for elimination in Brazil: the case of schistosomiasis mansoni","volume":"114","author":"Nascimento GL","year":"2019","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-3156.1998.00248.x","article-title":"An investigation into the interaction between drug efficacy and drug price of praziquantel in determining the cost-effectiveness of school-targeted treatment for Schistosoma mansoni using a population dynamic model","volume":"3","author":"Guyatt HL","year":"1998","journal-title":"Trop Med Int Health"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1017\/S0031182099006101","article-title":"A population dynamic approach to evaluating the impact of school attendance on the unit cost and effectiveness of school-based schistosomiasis chemotherapy programmes","volume":"121","author":"Carabin H","year":"2000","journal-title":"Parasitology"},{"key":"ref41","first-page":"667","article-title":"Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis","volume":"77","author":"Boelaert M","year":"1999","journal-title":"Bull World Health Organ"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1365-3156.2002.00959.x","article-title":"How better drugs could change kala-azar control: lessons from a cost-effectiveness analysis","volume":"7","author":"Boelaert M","year":"2002","journal-title":"Trop Med Int Health"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-3156.2006.01782.x","article-title":"Drug policy for visceral leishmaniasis: a cost-effectiveness analysis","volume":"12","author":"Vanlerberghe V","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1590\/0102-311X00158614","article-title":"Study of implementation and direct cost estimates for diagnostic tests for human visceral leishmaniasis in an urban area in Brazil","volume":"31","author":"Machado de Assis TS","year":"2015","journal-title":"Cad Saude Publica"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/trstmh\/trw050","article-title":"Cost-effectiveness analysis of diagnostic tests for human visceral leishmaniasis in Brazil","volume":"110","author":"Machado de Assis TS","year":"2016","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref46","article-title":"Budgetary impact of diagnostic tests for visceral leishmaniasis in Brazil","volume":"33","author":"Machado de Assis TS","year":"2017","journal-title":"Cad Saude Publica"},{"key":"ref47","article-title":"Cost-effectiveness analysis of diagnostic-therapeutic strategies for visceral leishmaniasis in Brazil","volume":"52","author":"Machado de Assis TS","year":"2019","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref48","first-page":"931","article-title":"Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison","volume":"72","author":"Thakur CP","year":"1994","journal-title":"Bull World Health Organ"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1080\/00034983.1998.11813337","article-title":"Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex","volume":"92","author":"Sundar S","year":"1998","journal-title":"Ann Trop Med Parasitol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0035-9203(00)90277-3","article-title":"Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis","volume":"94","author":"Sundar S","year":"2000","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-3156.2009.02306.x","article-title":"Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India","volume":"14","author":"Olliaro P","year":"2009","journal-title":"Trop Med Int Health"},{"key":"ref52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000818","article-title":"Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent","volume":"4","author":"Meheus F","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1590\/0037-8682-0133-2017","article-title":"The direct costs of treating human visceral leishmaniasis in Brazil","volume":"50","author":"Machado de Assis TS","year":"2017","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/tmi.12994","article-title":"Cost of visceral leishmaniasis care in Brazil","volume":"22","author":"Carvalho IP","year":"2017","journal-title":"Trop Med Int Healt"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/tmi.13284","article-title":"Treatment for human visceral leishmaniasis: a cost-effectiveness analysis for Brazil","volume":"24","author":"Carvalho IP","year":"2019","journal-title":"Trop Med Int Health"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1590\/S0102-311X2009001200002","article-title":"Avalia\u00e7\u00e3o econ\u00f4mica em sa\u00fade: aplica\u00e7\u00f5es em doen\u00e7as infecciosas","volume":"25","author":"Vanni T","year":"2009","journal-title":"Cad Saude Publica"},{"key":"ref57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001250","article-title":"Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women","volume":"5","author":"Carlier Y","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"ref58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001479","article-title":"Multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate Bancroftian filariasis","volume":"6","author":"Gass K","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003319","article-title":"Progress and impact of 13 years of the Global Programme to Eliminate Lymphatic Filariasis on Reducing the Burden of Filarial Disease","volume":"8","author":"Ramaiah KD","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref60","first-page":"43","article-title":"Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review","volume":"10","author":"Srividya A","year":"2019","journal-title":"Res Rep Trop Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s40249-017-0370-7","article-title":"Elimination of schistosomiasis: the tools required","volume":"6","author":"Bergquist R","year":"2017","journal-title":"Infect Dis Poverty"},{"key":"ref62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006277","article-title":"Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain","volume":"12","author":"Bangert M","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fpubh.2018.00052","article-title":"Systematic review of health economic evaluation studies developed in Brazil from 1980 to 2013","volume":"6","author":"Decimoni TC","year":"2018","journal-title":"Front Public Health"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/rimtsp\/v63\/1678-9946-rimtsp-63-S1678-9946202163041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:17:42Z","timestamp":1621887462000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652021000100404&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":63,"alternative-id":["S0036-46652021000100404"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202163041","relation":{},"ISSN":["1678-9946"],"issn-type":[{"value":"1678-9946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"e41"}}